Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes
Clinical trial NCT03132181 · COMPLETED
Trial details
- NCT number
- NCT03132181
- Sponsor
- RWTH Aachen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2019-01-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.